Table 5.
Pathway activities for DLCL2 cells based on 13C LC-MS data.a
| Pathway name | Control | Rapamycin | P-value |
|---|---|---|---|
| Reductive carboxylation (cytosolic) | 0.29 ± 0.05 | 0.17 ± 0.03 | 0.0235 |
| Glutaminolysis | 0.27 ± 0.10 | 0.014 ± 0.02 | 0.0122 |
| Mitochondrial pyruvate carrier | 0.63 ± 0.06 | 0.90 ± 0.09 | 0.0124 |
| Pyruvate dehydrogenase complex | 0.60 ± 0.07 | 0.56 ± 0.05 | 0.466 |
| Pyruvate carboxylase (mitochondrial) | 0.075 ± 0.030 | 0.39 ± 0.09 | 0.0045 |
| De Novo fatty acid production | 0.39 ± 0.07 | 0.23 ± 0.05 | 0.0322 |
aPresented as real parameter value ± error in terms of standard deviation (SD). Errors are based on Monte Carlo simulations assuming Gaussian noise with 0 mean and σ = 0.01 for SD; synthetic renormalized steady-state mass-isotopomers fit by fragmented cumomer model using Simplex.